Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Oumar Yattara"'
Autor:
Modibo Diarra, Drissa Coulibaly, Amadou Tapily, Boureima Guindo, Koualy Sanogo, Diakalia Koné, Youssouf Koné, Karim Koné, Aboudramane Bathily, Oumar Yattara, Mahamadou A. Thera, Alassane Dicko, Abdoulaye A. Djimdé, Issaka Sagara
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 6, Iss 1, p 13 (2021)
In Mali, since 2007, artemether-lumefantrine has been the first choice against uncomplicated malaria. Despite its effectiveness, a rapid selection of markers of resistance to partner drugs has been documented. This work evaluated the treatment accord
Externí odkaz:
https://doaj.org/article/a357a048ccf44a6d89a5750c123d7e90
Autor:
Diakalia Koné, Oumar Yattara, Boureima Guindo, Abdoulaye Djimde, Modibo Diarra, Mahamadou A. Thera, Alassane Dicko, Drissa Coulibaly, Karim Koné, Koualy Sanogo, Youssouf Koné, Issaka Sagara, Aboudramane Bathily, Amadou Tapily
Publikováno v:
Tropical Medicine and Infectious Disease
Tropical Medicine and Infectious Disease, MDPI, 2021, 6 (1), pp.13. ⟨10.3390/tropicalmed6010013⟩
Tropical Medicine and Infectious Disease, Vol 6, Iss 13, p 13 (2021)
Volume 6
Issue 1
Tropical Medicine and Infectious Disease, MDPI, 2021, 6 (1), pp.13. ⟨10.3390/tropicalmed6010013⟩
Tropical Medicine and Infectious Disease, Vol 6, Iss 13, p 13 (2021)
Volume 6
Issue 1
In Mali, since 2007, artemether-lumefantrine has been the first choice against uncomplicated malaria. Despite its effectiveness, a rapid selection of markers of resistance to partner drugs has been documented. This work evaluated the treatment accord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee90d036bcdea86a6bcb7379ff06f11d
https://www.hal.inserm.fr/inserm-03832308
https://www.hal.inserm.fr/inserm-03832308
Autor:
Modibo, Diarra, Drissa, Coulibaly, Amadou, Tapily, Boureima, Guindo, Koualy, Sanogo, Diakalia, Koné, Youssouf, Koné, Karim, Koné, Aboudramane, Bathily, Oumar, Yattara, Mahamadou A, Thera, Alassane, Dicko, Abdoulaye A, Djimdé, Issaka, Sagara
Publikováno v:
Tropical Medicine and Infectious Disease
In Mali, since 2007, artemether-lumefantrine has been the first choice against uncomplicated malaria. Despite its effectiveness, a rapid selection of markers of resistance to partner drugs has been documented. This work evaluated the treatment accord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cad0dfe7f5ace797f1b0541720a5c45d
https://pubmed.ncbi.nlm.nih.gov/33498803
https://pubmed.ncbi.nlm.nih.gov/33498803
Autor:
Bakary Fofana, Jacques Le Bras, Véronique Hubert, Cheick Papa Oumar Sangare, Halima Kaddouri, Aminatou Kone, Abdoulaye Djimde, Bakary Sidibe, Aly Kodio, Hamma Maiga, Oumar Yattara, Mamadou Tekete, Souleymane Dama, Ogobara K. Doumbo
Publikováno v:
International journal for parasitology. 38(7)
Plasmodium falciparum resistance to the former first-line antimalarials chloroquine and sulfadoxine/pyrimethamine has reached critically high levels in many malaria-endemic regions. This has spurred the introduction of several new artemisinin-based c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8168af7b0fe31613afcfc21f7da9bfd9
https://pubmed.ncbi.nlm.nih.gov/18406409
https://pubmed.ncbi.nlm.nih.gov/18406409
Autor:
Meredith McMorrow, Boubacar Traore, Ogobara K. Doumbo, Robert D. Newman, Younoussou Kone, Annett Hoppe, Renion Saye, Hamidou Traore, Oumar Yattara, Etienne A. Guirou, Hamma Maiga, Abdoulaye Djimde, Kassoum Kayentao
Publikováno v:
Malaria Journal, Vol 8, Iss 1, p 5 (2009)
Malaria Journal
Malaria Journal
Background Because of the emergence of chloroquine resistance in Mali, artemether-lumefantrine (AL) or artesunate-amodiaquine (AS+AQ) are recommended as first-line therapy for uncomplicated malaria, but have not been available in Mali until recently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff921ad7c0eb689a0cdbb953f04e9920